Health ministry proposes amendment to drug rules to bring antimicrobials under regulatory oversight
The Ministry of Health and Family Welfare in India has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, to bring antimicrobials under the Central regulatory framework that governs new drugs. This move aims to enhance oversight of antimicrobial quality, safety, and efficacy, and tackle the issue of antimicrobial resistance (AMR).
AMR is a significant global public health concern, necessitating coordinated efforts to address it. The G20 New Delhi Leaders' Declaration also emphasized the importance of addressing AMR through a One Health approach, which involves collaboration between humans, animals, and the environment.
The proposed amendment arises from concerns over the granting of manufacturing licenses for antimicrobial products without sufficient regulatory scrutiny. This includes the need for assessments such as bioavailability/bioequivalence and stability studies, which could impact the quality, safety, and efficacy of these products. Unreliable or ineffective antimicrobials can contribute to the emergence and spread of AMR, risking patient safety.
Under the proposed amendment, manufacturers would need to seek approval from the Central Licensing Authority (CLA) before applying for a manufacturing license from the State Licensing Authority (SLA). This additional regulatory step is expected to bolster Central regulatory oversight and ensure the quality, safety, and efficacy of antimicrobial products.
The draft notification, released on November 6, is open for objections and suggestions from stakeholders and the public before the Centre finalizes the proposed amendment. Antimicrobials are substances that kill microorganisms or inhibit their growth, encompassing medicines for treating or preventing infections, as well as topical agents for reducing microbes on skin or surfaces.
Written by urgent.news from Hindustan Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.